Two Sigma Advisers’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-84,952
| Closed | -$630K | – | 2384 |
|
|
2023
Q2 | $630K | Sell |
84,952
-48,964
| -37% | -$363K | ﹤0.01% | 1726 |
|
|
2023
Q1 | $1.27M | Sell |
133,916
-105,400
| -44% | -$996K | ﹤0.01% | 1511 |
|
|
2022
Q4 | $2.55M | Buy |
239,316
+195,100
| +441% | +$2.08M | 0.01% | 1109 |
|
|
2022
Q3 | $326K | Buy |
44,216
+18,800
| +74% | +$139K | ﹤0.01% | 2012 |
|
|
2022
Q2 | $122K | Buy |
+25,416
| New | +$122K | ﹤0.01% | 2365 |
|
|
2021
Q1 | – | Sell |
-10,000
| Closed | -$78K | – | 2547 |
|
|
2020
Q4 | $78K | Buy |
+10,000
| New | +$78K | ﹤0.01% | 2289 |
|